^
    Mercury™ employs highly sensitive and high-throughput technology to target these biomarkers to detect cancer as early as possible using liquid biopsies. For early cancer detection, the in vitro diagnostic kit uses highly sensitive next-generation sequencing-based technology MERCURY™ to assess multi-omics features of circulating free DNA (cfDNA) and detect tumorigenesis in health population.
    Cancer:
    Solid Tumor
    Method:
    Next-Generation Sequencing (NGS) / Liquid biopsy
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    01/24/23
    ST
    -
    CE